↑ Read the latest from the desks · fresh intelligence, published daily✦Quiet reading✦No ads, ever✦Ad-free articles read by humans today …↑✦Boards engagement today … people · … AI✦Corporate brand & media services✦Made in Virginia Beach since 1997✦
MiniMed Group$MMED · filed: grew revenue 14.3% in FY2026 to $3.1BWeathered boatNext year $2.8B–$4.1B sealedCheck ▾Close ▴
What MiniMed Group filed
Grew revenue 14.3% in FY2026 to $3.1 billion, operating margin -6.1% against a 1.2% median for surgical & medical instruments & apparatus, equity 78.0% of assets. Every figure links to the filing it came from on MiniMed Group’s card. Weathered boat: two warning signs.
What the house said in advance
Revenue for the fiscal year after 2026-04-24 between $2.8B and $4.1B, an 80% range sealed on 27 Sept 2026 · receipt #18902b · graded in public by the revenue in MiniMed Group’s next annual report.
Figures as filed with the SEC. Ranges, scores and boats are statistical descriptions of past filings, not ratings or recommendations. Reporting, not advice.
In plain words
MiniMed's **$644M** IPO isolates insulin pump economics from Medtronic, pricing at a discount that reflects legacy platform risk and interoperability tailwinds.
$644 million
IPO this week and expects the offering to close…
$1.8 billion
in annual pump revenue and removes the cross-subsidy dynamic…
3.2x
trailing revenue
4.1x
and Insulet's
Medtronic's MiniMed insulin pump unit priced a $644 million IPO this week and expects the offering to close early next week, completing a separation the parent company telegraphed for eighteen months. The move creates the first pure-play insulin pump public equity vehicle since Insulet's 2007 listing, at a moment when continuous glucose monitor tie-ins and closed-loop automation define competitive moats.
MiniMed dominated insulin delivery for two decades but lost ground as Tandem Diabetes Care paired pumps with Dexcom sensors and Insulet's tubeless Omnipod platform captured younger users. Medtronic's broader diabetes portfolio—glucose monitors, surgical instruments, hospital contracts—bundled the pump business into a structure that obscured standalone margin profile and constrained capital allocation. The separation isolates $1.8 billion in annual pump revenue and removes the cross-subsidy dynamic that kept R&D spending below peer levels.
The IPO prices MiniMed at roughly 3.2x trailing revenue, a discount to Tandem's 4.1x and Insulet's 6.7x multiples but consistent with slower growth and an installed base skewed toward older type-1 patients on legacy platforms. What allocators gain is direct exposure to the Medicare Advantage pump refresh cycle—an estimated 340,000 covered lives rotating onto upgraded devices between now and 2027—and the coming interoperability mandate that forces all pumps to accept third-party CGM data feeds by late 2025. MiniMed's 780G closed-loop system already runs Dexcom integration; the separation frees management to negotiate sensor partnerships without internal device conflict.
Medtronic retains a 19.4% stake post-IPO and two board seats, preserving some coordination on hospital channel access but ceding operational control. The parent's diabetes segment generated $2.3 billion last quarter; shedding the pump unit trims revenue but raises segment margin by an estimated 240 basis points as high-mix CGM and surgical products dominate the remaining portfolio. For MiniMed, independence means speed—procurement cycles compress from quarters to weeks, and partnership term sheets no longer route through Minneapolis legal.
Watch MiniMed's first earnings call in late April for updated guidance on Medicare Advantage penetration rates and any mention of acquisition interest in continuous ketone monitoring startups. Tandem's CEO already noted on the December earnings call that "consolidation makes sense once interoperability rules go live," a line that applies cleanly to a newly public, modestly valued competitor with an aging platform and distribution muscle. Medtronic's remaining stake comes off lockup in six months; any secondary sale before then signals the parent's view on standalone upside versus strategic sale probability.
The IPO closes the week of March 24. MiniMed's first quarterly report as a public company lands sixty days later, the same week the CMS interoperability compliance deadline gets its final regulatory language.
Branded by POPS4 · proof in 60 seconds
For the principal
Standalone MiniMed clarifies diabetes device exposure without Medtronic's hospital bundling; monitor Q2 guidance for Medicare refresh velocity and partnership announcements.
For the operator
IPO discount to Tandem and Insulet reflects slower growth; interoperability mandate in 2025 and Medicare Advantage refresh create two-year rerating window.
For the house
Huang Goodman holds Tandem and Insulet positions; MiniMed watchlist pending first quarterly guide and any indication of strategic interest post-lockup.
The branded-identity layer Chiefs of Staff and heritage CMOs route through — your name imprinted on real authorized stock, your pick of 200+ brands and 70,000 products, shipped from one accountable house. Nine editorial desks publish the intelligence those operators read before they sign.
200+authorized brands
70,000products · virtual proof on each
9 deskspublishing daily
1997one house, since
70,000 SKUs · virtual proof in 60 seconds · no platform fee · blind-shipped · ASI #217876
Your next customer won't visit your website. Their AI will.
AI assistants have quietly taken over the first step of buying — they answer from catalogs they can read and shortlist whoever can actually ship. Two questions now decide whether you exist to that buyer: can a machine read your catalog, and can you fulfill the order. Most brands fail one or both and never find out why the orders went elsewhere. The winners of this shift aren't the loudest. They're the most readable. Build for the machine that's about to do the shopping.
Built by the craft floor — apparel, media, packaging, and secure print.
This trade runs on hands, not desks. Imprint manufacturing & Komori heritage press through approved vendors · Canon high-speed secure-media operations is a craft floor — genuine Six Sigma discipline applied to ink, thread, foil, and registration, where a hundredth of an inch is the difference between a brand that reads serious and one that reads cheap. POPS4 is built by exactly those operators: independent, boots-on-the-ground engineers who carry their own book, read a client in microseconds, and put their name on every run. Beyond our own Virginia Beach floor, we work with a vetted network of craft manufacturers across the US — each meeting the highest excellence in QC standards in the industry, each a specialist in its own discipline — so apparel, hard-goods imprinting, media manufacturing, packaging, and secure printing all go to the bench built for them, coordinated from one accountable hub. Short-run from twenty-five units, volume to five hundred thousand. Two hundred authorized national brands, seventy thousand SKUs with virtual proofing on every one. Art archived for instant reorders. Net-thirty corporate terms, NDA-standard white-label — your name on the work, or none at all.
Strategy, positioning, identity, creative, and messaging — wired into an AI system that publishes and distributes on its own. Nine editorial desks generate the authority, the production house ships the physical proof, and the attribution layer tells you which post sold which SKU. What you get is an operating layer — content, catalog, and order path under one roof — that keeps working whether or not you are in the room. Built for principals who would rather own the machine than rent the agency.
Named-account programs — one desk, quiet delivery, NDA-standard.
One point of contact who already knows the file, so nothing restarts from zero between engagements. The work ships blind, under NDA, with your name on it or none at all. Built for single-family offices, heritage-house CMOs, sports-ownership groups, and the agencies that white-label our production. The relationship is the product; the merch is the proof of it.
SFO · Chief of Staff desk. Principal household, properties, aircraft, yacht, calendar, philanthropy — one file.
Shop seventy thousand products. Virtual proof on every one. 24/7.
Drop your logo on any product and see the virtual proof before asking. Quote routes direct to the desk. MCP catalog for AI agents. Celeste for the fast conversation. Full self-service checkout in development.
